- Approval Id
- 834ead4b99b812c8
- Drug Name
- UROKINASE-GREEN CROSS INJ. 60,000 iu/vial
- Product Name
- UROKINASE-GREEN CROSS INJ. 60,000 iu/vial
- Approval Number
- SIN11140P
- Approval Date
- 1999-10-05
- Registrant
- GRIFOLS ASIA PACIFIC PTE. LTD.
- Licence Holder
- GRIFOLS ASIA PACIFIC PTE. LTD.
- Drug Type
- Therapeutic
- Forensic Classification
- Prescription Only
- Dosage Form
- INJECTION, POWDER, FOR SOLUTION
- Dosage
- <p><strong>DOSAGE AND ADMINISTRATION</strong><br>
Reconstitute the contents of one vial with 10 mL of physiological saline and inject intravenously. Preferably instill as an admixture with physiological saline or glucose injection.</p>
<p>[Thrombotic-occulsive diseases]<br>
♦ Cerebral thrombosis: Administer 60,000 international units once a day for about 7 days.<br>
♦ Peripheral arterial-venous occlusion: Administer 60,000 to 240,000 international units on first day of treatment followed by tapered doses for about 7 days.</p>
- Route Of Administration
- INTRAVENOUS
- Indication Info
- <p><strong>INDICATIONS</strong><br>
Treatment of the following thrombotic-occlusive diseases:<br>
♦ Cerebral thrombosis (within 5 days after the onset of symptoms, and without hemorrhage detectable by computed tomography)<br>
♦ Peripheral arterial-venous occlusion (within 10 days after the onset of symptoms)</p>
- Contraindications
- <p><strong>(2) Contraindications</strong></p>
<ol class="decimalparen">
<li>Patients for whom hemostatic management is difficult: intracranial hemorrhage, hemoptysis, retroperitoneal hemorrhage and the like.</li>
<li>Patients having undergone intracranial or spinal surgery or with such injury (in the last 2 months).</li>
<li>Patients with aneurysm.</li>
<li>Patients with serious disturbances of consciousness.</li>
</ol>
<p><strong>(3) Contraindications as a general rule</strong><br>
This product is contraindicated in the following patients, as a general rule. If essential, however, it can be administered with caution.</p>
<ol class="decimalparen">
<li>Patients with atrial fibrillation (particularly with mitral stenosis), patients with infective endocarditis, patients with old myocardial infarction, and patients with a prosthetic valve.</li>
<li>Patients with neurological signs and symptoms of stroke which became complete instantaneously.</li>
</ol>
- Atc Code
- B01AD04
- Atc Item Name
- urokinase
- Pharma Manufacturer Name
- GRIFOLS ASIA PACIFIC PTE. LTD.
